Quantitative chemiluminescent immunoassay for NF-κB- DNA binding activity

Journal of Immunoassay and Immunochemistry

Volumn 26, Issue 2, 2005, Pages 125-143

  Gupta, Smiti V ^a   McGowen, Richard M ^a   Callewaert, Denis M ^b   Brown, Thomas R ^b   Li, Yiwei ^c   Sarkar, Fazlul H ^c  

^a Oxford Biomedical Research   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Assay; Cell extracts; Chemiluminescent immunoassay; Human lymphocytes; NF B; Oxidative stress; Quantitative; Rat liver

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; BINDING KINETICS; CANCER; CANCER CELL CULTURE; CELL NUCLEUS; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; DIABETES MELLITUS; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LIVER HOMOGENATE; LYMPHOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

ANIMALS; CELL LINE, TUMOR; CHEMILUMINESCENT MEASUREMENTS; CYTOSOL; DNA; DNA-BINDING PROTEINS; HUMANS; IMMUNOASSAY; LIVER; LYMPHOCYTES; MALE; NF-KAPPA B; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 15544390692     PISSN: 15321819     EISSN: None     Source Type: Journal    
DOI: 10.1081/IAS-200051996     Document Type: Article

References (21)

1. Bowie, A.a.O.N.L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol., Biochem. Pharmacol. 2000, 59, 13-23.
2. Finkel, T. Redox-dependent signal transduction. FEBS Lett. 2000, 476, 52-54.
3. Owuor, E.D.; Kong, A.N. Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmacol. 2002, 64, 765-770.
4. Martindale, J.L.; Holbrook, N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 2002, 192, 1-15.
5. Yoshizumi, M.; Tsuchiya, K.; Tamaki, T. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease. J. Med. Invest. 2001, 48, 11-24.
6. Ho, E.; Bray, T.M. Antioxidants, NFkappaB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 1999, 222, 205-213.
7. Lenardo, M.J.; Baltimore, D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58, 227-229.
8. Chen, F.; Castranova, V.; Shi, X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am. J. Pathol. 2001, 159, 387-397.
9. Haefner, B. NF-kappa B: arresting a major culprit in cancer. Drug Discov. Today 2002, 7, 653-663.
10. Karin, M.; Yamamoto, Y.; Wang, Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Natl. Rev. Drug Discov. 2004, 3, 17-26.
11. Ghosh, G.; van Duyne, G.; Ghosh, S.; Sigler, P.B. Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 1995, 373, 303-310.
12. Chen, Z.J.; Parent, L.; Maniatis, T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996, 84, 853-862.
13. Chinni, S.R.; Li, Y.; Upadhyay, S.; Koppolu, P.K.; Sarkar, F.H. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001, 20, 2927-2936.
14. Parker, C.S.; Topol, J.A. Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity. Cell 1984, 36, 357-369.
15. Davis, J.N.; Kucuk, O.; Djuric, Z.; Sarkar, F.H. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Rad. Biol. Med. 2001, 30, 1293-1302.
16. Davis, J.N.; Kucuk, O.; Sarkar, F.H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer 1999, 35, 167-74.
17. Bayer, E.A. The avidin-biotin system. In Immunoassay; Diamandis, E.P., Ed.; Academic Press: New York, 1998.
18. Toledano, M.B.; Leonard, W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 4328-4332.
19. Baeuerle, P.A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1991, 7072, 63-80.
20. Ghosh, S.; Baltimore, D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 1990, 344, 678-682.
21. Sundari, P.N.; Wilfred, G.; Ramakrishna, B. Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat? Biochim. Biophys. Acta 1997, 1362, 169-176.